Clinical trial
Randomized Study on the Efficacy and Safety of Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation
NCT00383864 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study on the Efficacy and Safety of Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2001
- Completion date
- March 31, 2006
- Enrollment
- 55
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.